Has Joseph Lasky received payments from drug or device companies?

Yes. Drug and device makers reported $16,309 in general payments to Joseph Lasky across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph Lasky did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph Lasky come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph Lasky

Pediatric Hematology-Oncology · Las Vegas, NVNPI 1386680718

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by CSL Behring at 36.0% of the total. Reporting peaked in 2020 at $6,157 and has fallen 70.6% since, to $1,812 in 2025.

$16,309in general payments, 2019–2025

Across 113 payments — averaging $144.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Behring$6K
Bayer$4K
Novo Nordisk$849
Bio Products Laboratory USA, Inc.$636
Spark Therapeutics, Inc.$474
Sanofi$463
plus $4K from 32 others

$159,615in research payments, 2019–2025

Across 83 payments — averaging $1923.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bioverativ Therapeutics Inc.$51K
Sanofi US Services Inc.$36K
Takeda Pharmaceuticals U.S.A., Inc.$18K
AbbVie$12K
CSL Behring$11K
Biogen$8K
plus $23K from 7 others

What the payments were for

Consulting fees$3,40021%
Speaking & faculty fees$5,87836%
Food & beverage$7,02143%
Education$90%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Behring	1	$5,878
Bayer	16	$4,158
Novo Nordisk	12	$849
Bio Products Laboratory USA, Inc.	8	$636
Spark Therapeutics, Inc.	6	$474
Sanofi	5	$463
Jazz Pharmaceuticals Inc.	4	$440
AstraZeneca	4	$367
Day One Biopharmaceuticals	3	$279
Springworks Therapeutics, Inc.	2	$252
Kedrion Biopharma, Inc.	3	$240
Grifols Shared Services North America, Inc.	3	$228
Pharming Healthcare, Inc.	4	$193
Novartis	2	$148
Y-mabs Therapeutics, Inc.	2	$145
Genentech USA, Inc.	2	$144
Servier Pharmaceuticals LLC	1	$138
Intrabio Inc	2	$136
Sanofi-aventis U.S. LLC	1	$120
Janssen Scientific Affairs, LLC	1	$115
Pfizer	6	$112
Sobi, Inc	1	$107
Octapharma USA, Inc.	3	$90
USWM, LLC	2	$83
Shire North American Group Inc	2	$83
Takeda Pharmaceuticals U.S.A., Inc.	3	$80
Chiesi USA, Inc.	2	$59
Adaptive Biotechnologies Corporation	2	$55
Pharmacosmos Therapeutics Inc.	1	$35
Regeneron Healthcare Solutions, Inc.	1	$33
Syndax Pharmaceuticals, Inc.	1	$29
Apellis Pharmaceuticals, Inc.	1	$24
Medexus Pharma, Inc.	1	$23
Grifols USA, LLC	1	$22
Incyte Corporation	1	$20
RARE Disease Therapeutics, Inc.	1	$19
Sanofi US Services Inc.	1	$17
Genetix Biotherapeutics Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Las Vegas

Daisy CortesLas Vegas$385K
Jenny Gober McDanielLas Vegas$43K
Aimee FoordLas Vegas$41K
Nik Nik Abdul RashidLas Vegas$32K
Jerry ReevesLas Vegas$12K
Waseem AlhushkiLas Vegas$3K
Alan IkedaLas Vegas$1K
Michael GrahamLas Vegas$1K
Sumit GuptaLas Vegas$1K
Raul Montiel-EsparzaLas Vegas$794

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →